Gilead CEO Daniel O’Day Sells $19.69 Million of Stock Under 10b5-1 Plan
Gilead Sciences, Inc. Chairman and Chief Executive Officer Daniel Patrick O’Day sold 112,429 shares for $19,693,439 on Nov. 4 and Nov. 5, 2026 after exercising employee stock options, according to a Form 4 filed Friday.
The filing shows option exercises totaling 112,429 shares at a strike price of $72.34. O’Day then sold 112,429 shares in open-market trades at a weighted-average sale price of $175.16. The sales were made under a Rule 10b5-1 trading plan adopted on Feb. 25, 2026, according to the filing.
After the transactions, O’Day owned 551,683 Gilead shares, according to the Form 4.
Sources
- Gilead Form 4 for Chairman and CEO Daniel Patrick O’Day option exercises and sales, filed Nov. 6, 2026 (accession 0001638643-26-000040)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.